FDA Approves VectorY’s ALS Trial Targeting TDP-43
VectorY Therapeutics, a biopharmaceutical company, has been cleared by the FDA to proceed with its PIONEER-ALS Phase I/II clinical trial of VTx-002, an antibody targeting toxic…
Tag: Drug Trials
AbbVie Submits NDA for Tavapadon: A New Hope for Parkinson’s Patients
The biopharmaceutical company, AbbVie, submitted a New Drug Application (NDA) to the U.S. Food & Drug Administration (FDA) for Tavapadon, a new drug targeting the…